Deferred Tax Assets, Valuation Allowance of Evolent Health, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Evolent Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Evolent Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $74,878,000, a 57% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Evolent Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $74,878,000 +$27,034,000 +57% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q4 2024 $47,844,000 +$15,840,000 +49% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q4 2023 $32,004,000 -$38,786,000 -55% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $70,790,000 -$30,555,000 -30% 31 Dec 2022 10-K 23 Feb 2024 2023 FY
Q4 2021 $101,345,000 +$11,622,000 +13% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q4 2020 $89,723,000 +$38,908,000 +77% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $50,815,000 +$13,778,000 +37% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $37,037,000 -$16,164,000 -30% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $53,201,000 +$26,825,000 +102% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $26,376,000 +$6,402,000 +32% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q4 2015 $19,974,000 +$13,059,000 +189% 31 Dec 2015 10-K 03 Mar 2017 2016 FY
Q4 2014 $6,915,000 31 Dec 2014 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.